Professor Xenofon Baraliakos, EULAR president-elect, discusses personalised treatment and other challenges and opportunities ...

Study finds perioperative pembrolizumab plus neoadjuvant chemotherapy in early-stage NSCLC is safe, effective and improves ...

Professor Antonio Almeida shares plans for his EHA presidency, key takeaways from its Congress and thoughts on clinical ...

Rapid Response Systems (RRS) used by hospitals to stabilise in-patient deterioration in children varies considerably between European countries and hospitals. A new study has revealed significant ...

Switching to biosimilars when treating patients with haematological cancers does not increase the risk of adverse events, ...

A new ESPR survey examines how lung ultrasound is used in NICUs across Europe to better understand how this may be improved.

Sign up today to receive the latest clinical news, analysis, expert opinion, and research for senior stakeholders in hospitals across Europe.

A new nuclear medicine and molecular radiotherapy suite is streamlining and personalising cancer care, as Professor Jon ...